Current Cancer Drug Targets,
Journal Year:
2023,
Volume and Issue:
24(3), P. 288 - 307
Published: July 13, 2023
This
review
describes
the
comprehensive
portrait
of
tumor
microenvironment
(TME).
Additionally,
we
provided
a
panoramic
perspective
on
transformation
and
functions
diverse
constituents
in
TME,
underlying
mechanisms
drug
resistance,
beginning
with
immune
cells
metabolic
dynamics
within
TME.
Lastly,
summarized
most
auspicious
potential
therapeutic
strategies.
Biomedicines,
Journal Year:
2024,
Volume and Issue:
12(4), P. 743 - 743
Published: March 27, 2024
Mesenchymal
stem
cells
(MSCs)
have
been
recognized
as
a
cell
therapy
with
the
potential
to
promote
skin
healing.
MSCs,
their
multipotent
differentiation
ability,
can
generate
various
related
wound
healing,
such
dermal
fibroblasts
(DFs),
endothelial
cells,
and
keratinocytes.
In
addition,
MSCs
neovascularization,
cellular
regeneration,
tissue
healing
through
mechanisms
including
paracrine
autocrine
signaling.
Due
these
characteristics,
extensively
studied
in
context
of
burn
chronic
repair.
Furthermore,
during
investigation
unique
roles
aging
scarless
also
discovered.
this
review,
we
summarize
by
which
discuss
recent
findings
from
preclinical
clinical
studies.
We
explore
strategies
enhance
therapeutic
effects
MSCs.
Moreover,
emerging
trend
combining
engineering
techniques,
leveraging
advantages
materials,
biodegradable
scaffolds
hydrogels,
repair
capacity
Additionally,
highlight
using
characteristics
cell-free
therapies
future
direction
cell-based
treatments,
further
demonstrating
regenerative
aesthetic
applications
regeneration.
Journal of Hematology & Oncology,
Journal Year:
2025,
Volume and Issue:
18(1)
Published: Jan. 13, 2025
The
tumor
microenvironment
(TME)
is
integral
to
cancer
progression,
impacting
metastasis
and
treatment
response.
It
consists
of
diverse
cell
types,
extracellular
matrix
components,
signaling
molecules
that
interact
promote
growth
therapeutic
resistance.
Elucidating
the
intricate
interactions
between
cells
TME
crucial
in
understanding
progression
challenges.
A
critical
process
induced
by
epithelial-mesenchymal
transition
(EMT),
wherein
epithelial
acquire
mesenchymal
traits,
which
enhance
their
motility
invasiveness
progression.
By
targeting
various
components
TME,
novel
investigational
strategies
aim
disrupt
TME's
contribution
EMT,
thereby
improving
efficacy,
addressing
resistance,
offering
a
nuanced
approach
therapy.
This
review
scrutinizes
key
players
emphasizing
avenues
therapeutically
components.
Moreover,
article
discusses
implications
for
resistance
mechanisms
highlights
current
toward
modulation
along
with
potential
caveats.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(17), P. 9463 - 9463
Published: Aug. 30, 2024
Colorectal
cancer
(CRC)
represents
a
significant
global
health
burden,
with
high
incidence
and
mortality
rates
worldwide.
Recent
progress
in
research
highlights
the
distinct
clinical
molecular
characteristics
of
colon
versus
rectal
cancers,
underscoring
tumor
location's
importance
treatment
approaches.
This
article
provides
comprehensive
review
our
current
understanding
CRC
epidemiology,
risk
factors,
pathogenesis,
management
strategies.
We
also
present
intricate
cellular
architecture
colonic
crypts
their
roles
intestinal
homeostasis.
carcinogenesis
multistep
processes
are
described,
covering
conventional
adenoma-carcinoma
sequence,
alternative
serrated
pathways,
influential
Vogelstein
model,
which
proposes
sequential
Cancers,
Journal Year:
2025,
Volume and Issue:
17(3), P. 382 - 382
Published: Jan. 24, 2025
Cancer
stem
cells
(CSCs)
play
a
central
role
in
tumor
progression,
recurrence,
and
resistance
to
conventional
therapies,
making
them
critical
focus
oncology
research.
This
review
provides
comprehensive
analysis
of
CSC
biology,
emphasizing
their
self-renewal,
differentiation,
dynamic
interactions
with
the
microenvironment
(TME).
Key
signaling
pathways,
including
Wnt,
Notch,
Hedgehog,
are
discussed
detail
highlight
potential
as
therapeutic
targets.
Current
methodologies
for
isolating
CSCs
critically
examined,
addressing
advantages
limitations
advancing
precision
medicine.
Emerging
technologies,
such
CRISPR/Cas9
single-cell
sequencing,
explored
transformative
unraveling
heterogeneity
informing
strategies.
The
also
underscores
pivotal
TME
supporting
survival,
promoting
metastasis,
contributing
resistance.
Challenges
arising
from
CSC-driven
dormancy
analyzed,
along
strategies
mitigate
these
barriers,
novel
therapeutics
targeted
approaches.
Ethical
considerations
integration
artificial
intelligence
designing
CSC-specific
therapies
essential
elements
future
manuscript
advocates
multi-disciplinary
approach
that
combines
innovative
advanced
therapeutics,
collaborative
research
address
complexities
CSCs.
By
bridging
existing
gaps
knowledge
fostering
advancements
personalized
medicine,
this
aims
guide
development
more
effective
cancer
treatment
strategies,
ultimately
improving
patient
outcomes.
Oncology Letters,
Journal Year:
2025,
Volume and Issue:
29(5), P. 1 - 17
Published: March 4, 2025
The
expression
of
cytosolic
aldehyde
dehydrogenases
(ALDHs),
which
mediate
the
last
step
in
pathway
synthesis
all‑trans
retinoic
acid,
is
dysregulated
various
types
human
cancer,
and
has
been
associated
with
development
cancer
stem
cells
(CSCs)
solid
tumors
hematological
malignancies.
CSCs
are
considered
a
minor
fraction
capacity
to
initiate
neoplastic
tumors.
ALDH1A1
serves
crucial
role
emergence
CSC
phenotype,
induces
malignant
behavior
promotes
treatment
resistance.
Notably,
ALDH1A1‑induced
therapy
resistance
not
exclusive
just
one
group
drugs,
but
affects
diverse
drugs
that
use
different
mechanisms
kill
cells.
This
diversity
drug
resistance‑inducing
effects
stemness‑supporting
functions
ALDH1A1.
inhibition
activity
using
chemicals
or
depletion
via
genetic
approaches,
such
as
small
interfering
RNA,
can
overcome
pathways
In
context
breast
it
critical
only
expected
manifest
stem‑like
features,
include
increased
From
angle
disease
prognosis,
extent
association
remains
be
determined
through
application
cutting‑edge
methods
detect
tracked
biomarkers
within
Cancers,
Journal Year:
2025,
Volume and Issue:
17(7), P. 1234 - 1234
Published: April 5, 2025
Background/Objectives:
The
significance
of
cytokine
signaling
on
cancer
progression
and
metastasis
has
raised
interest
in
research
over
the
last
few
decades.
Here,
we
analyzed
effects
three
cytokines
that
previously
reported
are
significantly
upregulated
rapidly
after
surgical
removal
primary
breast,
colorectal,
prostate
cancer.
We
also
investigated
regulation
their
cognate
receptors.
Methods:
All
experiments
were
conducted
using
PANC-1,
SW620,
MCF-7
cell
lines,
treated
with
different
(TGF-β1,
HGF,
IL-6).
effect
these
expression
epithelial-mesenchymal
transition
(EMT)
surface
markers
neuraminidase-1
activity
was
measured
via
fluorescent
microscopy
image
analysis
software.
Results:
findings
show
increase
mesenchymal
while
reducing
epithelial
markers,
corresponding
to
EMT
process.
A
strong
link
between
receptor
Neu-1-MMP-9-GPCR
crosstalk
identified,
suggesting
binding
leads
increased
Neu-1
subsequent
pathway
activation.
Oseltamivir
phosphate
(OP)
prevented
sialic
acid
hydrolysis
by
(Neu-1),
leading
downregulation
cascades.
Conclusions:
In
concert
previous
work
revealing
role
regulating
other
glycosylated
receptors
implicated
proliferation
EMT,
targeting
may
provide
effective
treatment
against
a
variety
malignancies.
Most
significantly,
patients
specific
inhibitors
soon
surgery
improve
our
ability
cure
early-stage
inhibiting
process
disrupting
any
residual
population
metastasize.
Technology in Cancer Research & Treatment,
Journal Year:
2024,
Volume and Issue:
23
Published: Jan. 1, 2024
Colorectal
cancer
(CRC)
is
the
third
most
frequently
found
in
world,
and
it
discovered
when
already
far
along
its
development.
About
20%
of
cases
CRC
are
metastatic
incurable.
There
more
evidence
that
colorectal
stem
cells
(CCSCs),
which
charge
tumor
growth,
recurrence,
resistance
to
treatment,
what
make
so
different.
Because
we
know
about
cell
biology,
quickly
learned
molecular
processes
possible
cross-talk
between
signaling
pathways
affect
balance
gut
cancer.
Wnt,
Notch,
TGF-β,
Hedgehog
examples
pathway
members
whose
genes
may
change
produce
CCSCs.
These
control
self-renewal
pluripotency
SCs
then
decide
function
phenotype
However,
terms
their
ability
create
tumors
susceptibility
chemotherapeutic
drugs,
CSCs
differ
from
normal
bulk
cells.
This
be
reason
for
higher
rate
recurrence
patients
who
underwent
both
surgery
chemotherapy
treatment.
Scientists
have
a
group
uncontrolled
miRNAs
related
CCSCs
stemness
properties.
CCSC
functions
like
changing
expression
cycle
genes,
metastasis,
drug
mechanisms.
CCSC-related
mostly
signal
known
important
biology.
The
biomarkers
(CD
markers
miRNA)
diagnostic
roles
main
topics
this
review
study.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(13), P. 7470 - 7470
Published: July 8, 2024
Colorectal
cancer
(CRC)
is
a
significant
public
health
challenge,
with
5-fluorouracil
(5-FU)
resistance
being
major
obstacle
to
effective
treatment.
Despite
advancements,
5-FU
remains
formidable
due
complex
mechanisms
such
as
alterations
in
drug
transport,
evasion
of
apoptosis,
dysregulation
cell
cycle
dynamics,
tumor
microenvironment
(TME)
interactions,
and
extracellular
vesicle
(EV)-mediated
pathways.
Traditional
chemotherapy
often
results
high
toxicity,
highlighting
the
need
for
alternative
approaches
better
efficacy
safety.
Phytochemicals
(PCs)
EVs
offer
promising
CRC
therapeutic
strategies.
PCs,
derived
from
natural
sources,
exhibit
lower
toxicity
can
target
multiple
pathways
involved
progression
resistance.
facilitate
targeted
delivery,
modulate
immune
response,
interact
TME
sensitize
cells
However,
potential
PCs
engineered
overcoming
reshaping
immunosuppressive
underexplored.
Addressing
this
gap
crucial
identifying
innovative
therapies
enhanced
reduced
toxicities.
This
review
explores
multifaceted
evaluates
synergistic
effects
combining
improve
treatment
while
minimizing
adverse
effects.
Additionally,
it
investigates
by
serving
delivery
vehicles
modulating
TME.
By
synthesizing
current
knowledge
addressing
research
gaps,
enhances
academic
understanding
CRC,
interdisciplinary
involving
revolutionizing
therapy.
Further
clinical
validation
are
essential
translating
these
findings
into
improved
patient
outcomes.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(16), P. 8647 - 8647
Published: Aug. 8, 2024
Cancer
stem
cells
represent
a
resilient
subset
within
the
tumor
microenvironment
capable
of
differentiation,
regeneration,
and
resistance
to
chemotherapeutic
agents,
often
using
dormancy
as
shield.
Their
unique
properties,
including
drug
metastatic
potential,
pose
challenges
for
effective
targeting.
These
exploit
certain
metabolic
processes
their
maintenance
survival.
One
these
is
autophagy,
which
generally
helps
in
energy
homeostasis
but
when
hijacked
by
CSCs
can
help
maintain
stemness.
Thus,
it
referred
an
Achilles
heel
CSCs,
cancers
tend
depend
on
autophagy
Autophagy,
while
crucial
maintaining
stemness
cancer
(CSCs),
also
serve
vulnerability
contexts,
making
complex
target
therapy.
Regulators
like
AMPK
(5'
adenosine
monophosphate-activated
protein
kinase)
play
role
helping
reprogramming
harsh
environments.
The
purpose
this
review
elucidate
interplay
between
highlighting
targeting
discussing
therapeutic
strategies
overcome
limitations.
This
focuses
previous
research
its
regulators
biology,
particularly
addresses
remaining
unanswered
questions,
potential
targets
therapy
are
brought
attention.